Freire Maria C has filed 18 insider transactions across 3 companies since June 2023.
Most recent transaction: a sale of 20634 shares of EXELIXIS, INC. ($EXEL) on May 07, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | S | Common Stock | 20634 | $46.00 | 100,819.0000 | 281,863,000 | 16.99% | 0.01% |
| May 7, 2026 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Common Stock | 20634 | $19.77 | 121,453.0000 | 281,863,000 | 20.47% | 0.01% |
| May 7, 2026 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Option (right to buy) | 20634 | $0.00 | 0.0000 | 281,863,000 | 100.00% | 0.01% |
| Jan. 15, 2026 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | $ARE | Freire Maria C | Director | A | Common Stock | 3493 | $0.00 | 10,946.0000 | 172,825,059 | 46.87% | 0.00% |
| June 17, 2025 | BIOGEN INC. | $BIIB | Freire Maria C | Director | A | Common Stock | 2370 | $0.00 | 6,815.0000 | 169,500,000 | 53.32% | 0.00% |
| May 29, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | A | Common Stock | 9812 | $0.00 | 100,819.0000 | 296,132,000 | 10.78% | 0.00% |
| Feb. 14, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Option (right to buy) | 28240 | $0.00 | 0.0000 | 296,132,000 | 100.00% | 0.01% |
| Feb. 14, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Common Stock | 15874 | $20.50 | 106,881.0000 | 296,132,000 | 17.44% | 0.01% |
| Feb. 14, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Common Stock | 28240 | $22.10 | 135,121.0000 | 296,132,000 | 26.42% | 0.01% |
| Feb. 14, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | S | Common Stock | 44114 | $34.94 | 91,007.0000 | 296,132,000 | 32.65% | 0.01% |
| Feb. 14, 2025 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | M | Option (right to buy) | 15874 | $0.00 | 0.0000 | 296,132,000 | 100.00% | 0.01% |
| Jan. 15, 2025 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | $ARE | Freire Maria C | Director | A | Common Stock | 2032 | $0.00 | 7,453.0000 | 0 | 37.48% | 0.00% |
| Aug. 14, 2024 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | S | Common Stock | 8250 | $26.56 | 91,007.0000 | 321,464,000 | 8.31% | 0.00% |
| June 21, 2024 | BIOGEN INC. | $BIIB | Freire Maria C | Director | A | Common Stock | 1340 | $0.00 | 4,445.0000 | 168,700,000 | 43.16% | 0.00% |
| May 31, 2024 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | A | Common Stock | 18838 | $0.00 | 99,257.0000 | 321,464,000 | 23.42% | 0.01% |
| Jan. 12, 2024 | ALEXANDRIA REAL ESTATE EQUITIES, INC. | $ARE | Freire Maria C | Director | A | Common Stock | 1585 | $0.00 | 5,421.0000 | 0 | 41.32% | 0.00% |
| June 26, 2023 | BIOGEN INC. | $BIIB | Freire Maria C | Director | A | Common Stock | 960 | $0.00 | 3,105.0000 | 167,900,000 | 44.76% | 0.00% |
| June 1, 2023 | EXELIXIS, INC. | $EXEL | Freire Maria C | Director | A | Common Stock | 20718 | $0.00 | 80,419.0000 | 324,556,000 | 34.70% | 0.01% |